\
Onvansertib effectively targets the once “undruggable” KRAS-mutation present in 50% of colorectal cancerNew Podcast

Turning the Tide on Cancer

Investing in Cardiff Oncology to Provide New Treatment Options for Cancers with the Greatest Medical Need

Events

William Blair Biotech Focus Conference Fireside Chat
 July 15, 2021
 9:00am - 9:45am PDT
William Blair Biotech Focus Conference

Dr. Mark Erlander, chief executive officer of Cardiff Oncology, will participate in a fireside chat at the William Blair Biotech Focus Conference on July 15, 2021. A replay of the webcast will be available until August 15, 2021.